1-(4-Bromophenyl)-1-(4-methoxyphenyl)methylamine, 97.0%, 1g

1,4-Dioxa-8-azaspiro[4.5]decane hydrochloride, 95.0%, 5g

tert-Butyl 2-amino-6,7-dihydrothiazolo[4,5-c]pyridine-5(4H)-carboxylate, 95.0%, 250mg

ETHYL 3-HYDROXYTETRAHYDROTHIOPHENE-3-CARBOXYLATE, 95.0%, 5g

(2-(2-Hydroxyethyl)phenyl)boronic acid, 97%, 1g

tert-Butyl 7-chloro-6-nitro-3,4-dihydroisoquinoline-2(1H)-carboxylate, 97%, 100mg

2-((tert-Butoxycarbonyl)amino)-2-(4-fluorophenyl)acetic acid, 95%, 250mg

2-Bromo-4-iodoanisole, 98.0%, 5g

Recipiente de cristalización ROTILABO® sin pico, 100 ml, 70 mm, 10 Unidad(es)

Methyl 2,4-dichlorophenylacetate, 95.0%, 5g

1-(2-Methoxyethyl)-6-oxo-1,6-dihydropyridine-3-carboxylic acid, 1g

(E)-2-(3-chloroprop-1-en-1-yl)-1,4-difluorobenzene, 95% mix TBC as stabilizer, 100mg

2-(4-Bromophenyl)-6-iodoimidazo[1,2-a]pyridine, 98.0%, 1g